Prevalence and predictors of pulmonary vascular disease in patients with advanced heart failure with reduced ejection fraction

Back

HFA Premium Access

Prevalence and predictors of pulmonary vascular disease in patients with advanced heart failure with reduced ejection fraction

Session: ePosters in valvular and pulmonary 3

Topic: Pulmonary Hypertension

Speaker: Doctor S. Vysocansky (Bratislava, SK)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Doctor Samuel Vysocansky

The National Institute of Cardiovascular Diseases, Bratislava (Slovakia)

1 presentation

0 follower

5 more presentations in this session

Estimating prognosis in connective tissue disease related pulmonary hypertension - the value of pulmonary artery compliance

Speaker: Doctor C. Gregorio (Lisbon, PT)

Access

Abstract

Slides

Pulmonary hypertension classification based on machine learning using standart chest X-ray:ATA artificial intelligence study-1

Speaker: Associate Professor T. Kivrak (Elazig, TR)

Access

Abstract

Slides

The particularities of cardiopulmonary exercise testing in patients with pulmonary hypertension and heart failure in the early period after myocardial revascularization.

Speaker: Mrs J. Cazacu (Chisinau, MD)

Access

Abstract

Slides

Four-strata risk-assessment tool for pulmonary hypertension: can we associate it with hemodynamic parameters?

Speaker: Doctor B. Silva (Lisbon, PT)

Access

Abstract

Slides

CTEPH: relevance of the new 2022 ESC/ERS definition of pulmonary hypertension and impact on diagnosis accuracy by right heart catheterization.

Speaker: Doctor B. Lacerda Teixeira (Lisbon, PT)

Access

Abstract

Slides

Access the full session

ePosters in valvular and pulmonary 3

Speakers: Doctor S. Vysocansky, Doctor C. Gregorio, Associate Professor T. Kivrak, Mrs J. Cazacu, Doctor B. Silva...

Access

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources